Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

每经AI快讯，海大集团（SZ 002311，收盘价：58.54元）11月19日晚间发布公告称，2025年11月19日， 公司首次通过回购专用证券账户以集中竞价方式回购公司股份约14万股，约占公司总股本的0.01%，最 高成交价58.5元/股，最低成交价为57.76元/股，成交总金额约为799万元。 每经头条（nbdtoutiao）——爱泼斯坦案文件解密倒计时，美国会"秒过"法案直通特朗普，引爆两党"极 限撕扯" （记者 曾健辉） 截至发稿，海大集团市值为974亿元。 2025年1至6月份，海大集团的营业收入构成为：饲料行业占比83.45%，苗种行业占比16.55%。 ...

广东海大集团股份有限公司（以下简称"公司"）分别于2025年10月28日、 2025年11月14日召开了第七届董事会第四次会议、2025年第四次临时股东会，审 议通过了《关于以集中竞价方式回购公司股份方案的议案》，同意公司以集中竞 价交易方式回购公司部分已在境内发行的A股股票，用于依法注销减少注册资本 及实施股权激励计划及/或员工持股计划。具体内容详见公司在指定信息披露媒 体《证券时报》《中国证券报》《上海证券报》《证券日报》和巨潮资讯网披露 的《关于以集中竞价方式回购公司股份方案的公告》《关于以集中竞价方式回购 公司股份方案的报告书》，公告编号：2025-055、2025-061。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号——回购股份》等相关规定，公司应当在首次回购股份事实发生的次日予以 披露。公司现将首次回购股份情况公告如下： 一、首次回购股份的具体情况 证券代码：002311 证券简称：海大集团 公告编号：2025-062 广东海大集团股份有限公司 关于首次实施以集中竞价交易方式回购公司股份的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、 ...

格隆汇11月19日丨海大集团(002311.SZ)公布，2025年11月19日，公司首次通过回购专用证券账户以集中 竞价方式回购公司股份137,600股，约占公司总股本的0.01%，最高成交价58.50元/股，最低成交价为 57.76元/股，成交总金额为7,994,119.00元（不含交易费用）。 ...

Core Viewpoint - The company, Haida Group, has initiated a share buyback program, indicating confidence in its stock value and future prospects [1] Summary by Categories Share Buyback Details - On November 19, 2025, the company repurchased 137,600 shares through a dedicated securities account via centralized bidding, representing approximately 0.01% of the total share capital [1] - The highest transaction price was 58.50 yuan per share, while the lowest was 57.76 yuan per share [1] - The total amount spent on the buyback was 7,994,119.00 yuan, excluding transaction fees [1]

Core Viewpoint - The company, Haida Group, announced its first share repurchase on November 19, 2025, through a centralized bidding method, indicating a commitment to enhancing shareholder value [1] Summary by Categories Share Repurchase Details - The company repurchased a total of 137,600 shares, which accounts for approximately 0.01% of the total share capital [1] - The highest transaction price was 58.50 CNY per share, while the lowest was 57.76 CNY per share [1] - The total amount spent on the repurchase was 7,994,119.00 CNY, excluding transaction fees [1] Compliance and Future Actions - The repurchase is in accordance with relevant regulations and the established plan [1] - The company plans to continue implementing the repurchase within the designated period and will disclose information in a timely manner [1]

Core Viewpoint - Haida Group's stock has shown a year-to-date increase of 23.27%, with recent fluctuations indicating a slight decline over the past five days and a modest increase over the past 20 days [1][2] Financial Performance - For the period from January to September 2025, Haida Group achieved a revenue of 96.094 billion yuan, representing a year-on-year growth of 13.24% [2] - The net profit attributable to shareholders for the same period was 4.142 billion yuan, reflecting a year-on-year increase of 14.31% [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Haida Group was 19,000, a decrease of 11.81% from the previous period [2] - The average number of circulating shares per shareholder increased by 13.39% to 87,561 shares [2] Dividend Distribution - Haida Group has cumulatively distributed 7.6 billion yuan in dividends since its A-share listing, with 3.739 billion yuan distributed over the last three years [3] Major Shareholders - As of September 30, 2025, the largest circulating shareholder was Hong Kong Central Clearing Limited, holding 70.8701 million shares, an increase of 8.015 million shares from the previous period [3] - Other notable shareholders include Invesco Great Wall New Growth Mixed Fund and Huatai-PineBridge CSI 300 ETF, with varying changes in their holdings [3] Stock Performance - As of November 19, Haida Group's stock price was 58.86 yuan per share, with a market capitalization of 97.928 billion yuan [1] - The stock experienced a trading volume of 159 million yuan and a turnover rate of 0.16% on the same day [1]

Core Viewpoint - The aquaculture sector in China is experiencing a significant surge, with multiple stocks reaching their daily limit up, indicating strong market interest and potential investment opportunities [1][3]. Industry Summary - As of November 19, several aquaculture stocks, including Guolian Aquatic (300094), have hit the daily limit up, reflecting a robust performance in the sector [1]. - Longjiang Securities reports that the Chinese aquaculture industry is expected to see a notable recovery by 2025, with major aquatic product prices rising to historical highs [3]. - Specific price increases include grass carp reaching 14 yuan/kg, a 25% increase from the beginning of the year, and prices for specialty aquatic products such as California bass and yellow catfish hitting 22.1 yuan/lb and 15.8 yuan/lb, respectively, both surpassing levels not seen since 2021 [3]. - The report suggests that this price rebound is a natural outcome following two years of stock adjustment in 2023 and 2024 [3].

Group 1 - The A-share market showed a strong rebound on November 19, with the ChiNext Index rising over 1.00%, the Shanghai Composite Index increasing by 0.47%, and the Shenzhen Component Index up by 0.46% [1] - The agricultural sector was notably active, with the China Securities Agricultural Index increasing by 0.40% [1] Group 2 - The Tianhong Agricultural ETF (512620) is set to be listed on November 21, tracking the China Securities Agricultural Index and covering sectors such as breeding and agricultural chemicals, with leading stocks including Muyuan Foods, Wens Foodstuff Group, and Haida Group [2] - The Ministry of Agriculture and Rural Affairs reported that over 80% of winter wheat has been sown nationwide, with significant progress in key provinces such as Henan (nearly 80%), Anhui (over 80%), and Shandong (nearly 90%) [2] - According to Guosheng Securities, the overall allocation in the agriculture, forestry, animal husbandry, and fishery sectors is currently low, below the standard allocation ratio, indicating potential investment opportunities [2] Group 3 - Kaisheng Securities noted that the previous overselling of live pigs, combined with a seasonal increase in consumption, may lead to a temporary strengthening of pig prices [3] - The supply side is expected to contract due to the overselling of live pigs in October and a reduction in breeding stock earlier in the year, while demand may increase due to a cold wave warning issued by the Central Meteorological Observatory on November 15 [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002311 证券简称：海大集团 公告编号：2025-061 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1、回购股份的种类：公司发行的人民币普通股（A股）。 2、 回购金额及资金来源：不低于人民币10亿元（含）且不超过16亿元（含）。本次回购所需资金来源 于公司自筹资金。 3、回购价格上限：不超过62.00元/股（含）。 4、回购数量：在回购股份价格不超过62.00元/股的条件下，按回购金额上限16亿元（含）测算，预计 回购股份数量不低于2,580.6451万股，占公司总股本的1.55%；按回购金额下限10亿元（含）测算，预 计回购股份数量不低于1,612.9033万股，占公司总股本的0.97%，具体回购股份的数量以回购期满时实 际回购的股份数量为准。 5、回购用途：本次回购股份将用于注销并减少注册资本及实施股权激励计划及/或员工持股计划，其中 10亿元回购股份将用于注销并减少注册资本，超过10亿元的回购股份将用于实施股权激励计划及/或员 工持股计划。 6、回购期限：自股东会审议 ...